
Top stories






HR & ManagementCnnect V2: Elevating employee experience with powerful new features
Cnnect 21 May 2025
More news










ESG & Sustainability
Why the future of climate change solutions hinges on Stem careers







In a research letter to the editor in the journal Epidemiology released Thursday, Drs. Joel Ray, Ivan Ying and colleagues explain they found high levels of enzymes known to be markers of liver disease in adults who had an acute stroke. Between 2005 and 2009, they reviewed 103 consecutive adults who had an MRI-proven acute stroke between 2005 and 2009 and compared them to 200 adults with suspected acute stroke, but whose MRI was normal, thereby ruling out acute stroke.
"The risk of stroke in relation to fatty liver disease has never been tested," Dr. Ray says. "Our study shows a strong link between the two and the possibility in future that currently available blood liver enzyme tests, or novel markers of fatty liver, may be used to predict the risk of stroke and help us better care for and treat at risk patients."
Non-alcoholic fatty liver disease is a common condition that often has no symptoms or complications. Risk factors include obesity, high cholesterol, diabetes and, especially, insulin resistance.
While the findings are promising, additional research is needed to validate the study's findings, Dr. Ray said.
Source: St. Michael's Hospital